PTX — Prescient Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$49.93m
- AU$31.49m
- AU$0.46m
- 53
- 14
- 55
- 38
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 1.04 | 1.75 | 1.15 | 1.46 | 2.04 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.2 | -2.32 | -3.97 | -4.31 | -6.19 |
Capital Expenditures | 0 | — | -0.002 | -0.004 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | — | -16 |
Purchase of Investments | |||||
Cash from Investing Activities | 0 | — | -0.002 | -0.004 | -16 |
Financing Cash Flow Items | -0.699 | 0 | -0.837 | 0 | -0.698 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.37 | 0 | 12.7 | 0.428 | 15.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.15 | -2.28 | 8.74 | -3.83 | -6.37 |